Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Athina Markou

Showing results (1-10 of 271) with videos related to

Pageof 28
Sort By:
Biological Psychiatry|August 1, 2006
Metabotropic glutamate receptor antagonists: novel therapeutics for nicotine dependence and depression?Athina Markou
Drug News & Perspectives|April 19, 2007
The role of metabotropic glutamate receptors in drug reward, motivation and dependenceAthina Markou
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 19, 2008
Accruing preclinical evidence about metabotropic glutamate 5 receptor antagonists as treatments for drug dependence highlights the irreplaceable contributions of animal studies to the discovery of new medications for human disordersAthina Markou
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|July 22, 2008
Review. Neurobiology of nicotine dependenceAthina Markou
Discovery Medicine|August 14, 2010
Nicotine dependence perpetuating tobacco smoking may be treatable by drugs acting at glutamate receptorsAthina Markou
CNS & Neurological Disorders Drug Targets|May 30, 2015
Metabotropic Glutamate Receptor 7 (mGluR7) as a Target for the Treatment of Psychostimulant DependenceXia Li, Athina Markou
Biological Psychiatry|December 4, 2003
Clozapine treatment attenuated somatic and affective signs of nicotine and amphetamine withdrawal in subsets of rats exhibiting hyposensitivity to the initial effects of clozapineSvetlana Semenova, Athina Markou
Biological Psychiatry|May 22, 2010
Disruption of performance in the five-choice serial reaction time task induced by administration of N-methyl-D-aspartate receptor antagonists: relevance to cognitive dysfunction in schizophreniaNurith Amitai, Athina Markou
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 15, 2010
The alpha2 adrenergic receptor antagonist idazoxan, but not the serotonin-2A receptor antagonist M100907, partially attenuated reward deficits associated with nicotine, but not amphetamine, withdrawal in ratsSvetlana Semenova, Athina Markou
Neuropharmacology|November 28, 2006
The effects of the mGluR5 antagonist MPEP and the mGluR2/3 antagonist LY341495 on rats' performance in the 5-choice serial reaction time taskSvetlana Semenova, Athina Markou
Pageof 28

Showing results (1-10 of 271) with videos related to

Sort By:
Pageof 28
Biological Psychiatry|August 1, 2006
Metabotropic glutamate receptor antagonists: novel therapeutics for nicotine dependence and depression?Athina Markou
Drug News & Perspectives|April 19, 2007
The role of metabotropic glutamate receptors in drug reward, motivation and dependenceAthina Markou
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 19, 2008
Accruing preclinical evidence about metabotropic glutamate 5 receptor antagonists as treatments for drug dependence highlights the irreplaceable contributions of animal studies to the discovery of new medications for human disordersAthina Markou
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|July 22, 2008
Review. Neurobiology of nicotine dependenceAthina Markou
Discovery Medicine|August 14, 2010
Nicotine dependence perpetuating tobacco smoking may be treatable by drugs acting at glutamate receptorsAthina Markou
CNS & Neurological Disorders Drug Targets|May 30, 2015
Metabotropic Glutamate Receptor 7 (mGluR7) as a Target for the Treatment of Psychostimulant DependenceXia Li, Athina Markou
Biological Psychiatry|December 4, 2003
Clozapine treatment attenuated somatic and affective signs of nicotine and amphetamine withdrawal in subsets of rats exhibiting hyposensitivity to the initial effects of clozapineSvetlana Semenova, Athina Markou
Biological Psychiatry|May 22, 2010
Disruption of performance in the five-choice serial reaction time task induced by administration of N-methyl-D-aspartate receptor antagonists: relevance to cognitive dysfunction in schizophreniaNurith Amitai, Athina Markou
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 15, 2010
The alpha2 adrenergic receptor antagonist idazoxan, but not the serotonin-2A receptor antagonist M100907, partially attenuated reward deficits associated with nicotine, but not amphetamine, withdrawal in ratsSvetlana Semenova, Athina Markou
Neuropharmacology|November 28, 2006
The effects of the mGluR5 antagonist MPEP and the mGluR2/3 antagonist LY341495 on rats' performance in the 5-choice serial reaction time taskSvetlana Semenova, Athina Markou
Pageof 28